Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

And this time, it’s not just fringe actors fanning the flames. It’s policymakers. It’s media personalities. It’s individuals ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

The new variant, NB.1.8.1, is also a subvariant of the Omicron variant. It has spread rapidly, and the earliest sample of ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Sen. Cassidy voices concerns over new ACIP members' lack of expertise in microbiology and mRNA vaccines after the ousting of ...